Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2013 1
2014 1
2016 4
2017 1
2018 2
2019 6
2020 4
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Preclinical Incorporation Dosimetry of [18F]FACH-A Novel 18F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET.
Sattler B, Kranz M, Wenzel B, Jain NT, Moldovan RP, Toussaint M, Deuther-Conrad W, Ludwig FA, Teodoro R, Sattler T, Sadeghzadeh M, Sabri O, Brust P. Sattler B, et al. Among authors: ludwig fa. Molecules. 2020 Apr 26;25(9):2024. doi: 10.3390/molecules25092024. Molecules. 2020. PMID: 32357571 Free PMC article.
Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.
Sadeghzadeh M, Wenzel B, Gündel D, Deuther-Conrad W, Toussaint M, Moldovan RP, Fischer S, Ludwig FA, Teodoro R, Jonnalagadda S, Jonnalagadda SK, Schüürmann G, Mereddy VR, Drewes LR, Brust P. Sadeghzadeh M, et al. Among authors: ludwig fa. Molecules. 2020 May 14;25(10):2309. doi: 10.3390/molecules25102309. Molecules. 2020. PMID: 32423056 Free PMC article.
Development and radiosynthesis of the first 18 F-labeled inhibitor of monocarboxylate transporters (MCTs).
Sadeghzadeh M, Moldovan RP, Fischer S, Wenzel B, Ludwig FA, Teodoro R, Deuther-Conrad W, Jonnalagadda S, Jonnalagadda SK, Gudelis E, Šačkus A, Higuchi K, Ganapathy V, Mereddy VR, Drewes LR, Brust P. Sadeghzadeh M, et al. Among authors: ludwig fa. J Labelled Comp Radiopharm. 2019 Jun 30;62(8):411-424. doi: 10.1002/jlcr.3739. J Labelled Comp Radiopharm. 2019. PMID: 31017677
(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls.
Tiepolt S, Becker GA, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J, Wagenknecht G, Sattler B, Deuther-Conrad W, Ludwig FA, Fischer S, Gertz HJ, Smits R, Hoepping A, Steinbach J, Brust P, Sabri O. Tiepolt S, et al. Among authors: ludwig fa. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):731-746. doi: 10.1007/s00259-020-05029-w. Epub 2020 Sep 16. Eur J Nucl Med Mol Imaging. 2021. PMID: 32935187 Free PMC article.
Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling.
Wodtke R, Hauser C, Ruiz-Gómez G, Jäckel E, Bauer D, Lohse M, Wong A, Pufe J, Ludwig FA, Fischer S, Hauser S, Greif D, Pisabarro MT, Pietzsch J, Pietsch M, Löser R. Wodtke R, et al. Among authors: ludwig fa. J Med Chem. 2018 May 24;61(10):4528-4560. doi: 10.1021/acs.jmedchem.8b00286. Epub 2018 May 10. J Med Chem. 2018. PMID: 29664627
In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine - A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET).
Ludwig FA, Fischer S, Houska R, Hoepping A, Deuther-Conrad W, Schepmann D, Patt M, Meyer PM, Hesse S, Becker GA, Zientek FR, Steinbach J, Wünsch B, Sabri O, Brust P. Ludwig FA, et al. Front Pharmacol. 2019 Jun 13;10:534. doi: 10.3389/fphar.2019.00534. eCollection 2019. Front Pharmacol. 2019. PMID: 31263411 Free PMC article.
27 results